Intralesional corticosteroid therapy for childhood cutaneous hemangiomas. 1994

N A Chowdri, and M A Darzi, and Z Fazili, and S Iqbal
Department of Plastic and Reconstructive Surgery, S.K. Institute of Medical Sciences, Soura, Srinagar, Kashmir, India.

Response to intralesional steroid therapy (triamcinolone acetonide and betamethasone acetate) was studied in 70 children of all ages with 74 cutaneous hemangiomas located in a variety of locations. One to seven injections were given without anesthesia with a mean interval of 6 weeks between the injections. Results analyzed 2 months after the last injection showed more than 75% reduction in volume in 43 (58.11%), 50% to 75% reduction in 16 (21.62%), 25% to 50% reduction in 9 (12.16%), and less than 25% reduction in 6 (8.11%) lesions. Response was not related to age, sex, or site of the lesion, but only 2 lesions (22.22%) with an initial volume of more than 20 cm3 showed more than 50% reduction. None showed regrowth within a mean follow-up period of 14 months. Transient cushingoid faces and hypopigmentation were noted in 2 patients each. We feel that intralesional steroid therapy is safe and effective for all cutaneous hemangiomas irrespective of site, sex, or age of the patient.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001623 Betamethasone A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724) Betadexamethasone,Flubenisolone,Celeston,Celestona,Celestone,Cellestoderm

Related Publications

N A Chowdri, and M A Darzi, and Z Fazili, and S Iqbal
March 1989, Plastic and reconstructive surgery,
N A Chowdri, and M A Darzi, and Z Fazili, and S Iqbal
January 2009, Annales Academiae Medicae Stetinensis,
N A Chowdri, and M A Darzi, and Z Fazili, and S Iqbal
October 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
N A Chowdri, and M A Darzi, and Z Fazili, and S Iqbal
July 2010, The British journal of dermatology,
N A Chowdri, and M A Darzi, and Z Fazili, and S Iqbal
January 2015, Turkish journal of medical sciences,
N A Chowdri, and M A Darzi, and Z Fazili, and S Iqbal
August 1984, Pediatrics,
N A Chowdri, and M A Darzi, and Z Fazili, and S Iqbal
September 2003, Cutis,
N A Chowdri, and M A Darzi, and Z Fazili, and S Iqbal
May 2017, Journal of the American Academy of Dermatology,
N A Chowdri, and M A Darzi, and Z Fazili, and S Iqbal
March 2000, Journal of pediatric surgery,
Copied contents to your clipboard!